重庆百亚卫生用品股份有限公司 未来三年（2025 年-2027 年）股东回报规划 为进一步健全和完善重庆百亚卫生用品股份有限公司（以下简称"公司"） 的股东回报机制，增强利润分配决策的透明度和可操作性，维护投资者合法权益， 结合企业盈利能力、经营发展规划、股东回报、社会资金成本以及外部融资环境 等因素，公司根据《公司法》《上市公司监管指引第 3 号——上市公司现金分红》 （三）现金分红的条件及比例 《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等 法律法规以及《公司章程》等相关文件要求，特制定了《重庆百亚卫生用品股份 有限公司关于未来三年（2025 年-2027 年）股份回报规划》（以下简称"本规划"）， 具体内容如下： 一、公司制定本规划考虑的因素 本规划的制定着眼于对投资者的合理回报和公司的可持续发展，公司在综合 考虑行业发展趋势、公司发展战略、业务开展状况、经营业绩、现金流量、财务 状况、社会资金成本及外部融资环境等重要因素基础上，建立持续、稳定、科学 的股东回报机制。 二、公司制定本规划的原则 本规划的制定应符合相关法律法规、规范性文件及《公司章程》的规定，应 当重视对投资者 ...

重庆百亚卫生用品股份有限公司 2025 年半年度非经营性资金占用及其他关联资金往来情况汇总表 编制单位：重庆百亚卫生用品股份有限公司 单位：万元 法定代表人：冯永林 主管会计工作的负责人：张黎 会计机构负责人：张黎 | | 资金占用方 | 占用方与上市公 | 上市公司核 | 年期初 2025 | 2025 年 月占 | 1-6 | 2025 年 1-6 | 月 | 2025 年 | 1-6 月 | 2025年6月30 | 占用形成 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 非经营性资金占用 | 名称 | 司的关联关系 | 算的会计科 | 占用资金余额 | 用累计发生金额 | | 占用资金的利 | | 偿还累计发生 | | 日占用资金余 | 原因 | | | | | | 目 | | （不含利息） | | 息（如有） | | | 金额 | 额 | | | | 控股股东、实际控制 | 无 | 不适用 | 不适用 | 无 | 无 | | 无 | | | 无 | 无 | ...

重庆百亚卫生用品股份有限公司 2025 年半年度财务报告 重庆百亚卫生用品股份有限公司 2025 年半年度财务报告 2025 年 8 月 1 重庆百亚卫生用品股份有限公司 2025 年半年度财务报告 2025 年半年度财务报告 一、审计报告 半年度报告是否经过审计 □是 否 公司半年度财务报告未经审计。 二、财务报表 财务附注中报表的单位为：元 1、合并资产负债表 编制单位：重庆百亚卫生用品股份有限公司 2025 年 06 月 30 日 单位：元 | 项目 | 期末余额 | 期初余额 | | --- | --- | --- | | 流动资产： | | | | 货币资金 | 343,542,529.00 | 394,655,417.00 | | 结算备付金 | | | | 拆出资金 | | | | 交易性金融资产 | 140,242,770.00 | 332,405,357.00 | | 衍生金融资产 | | | | 应收票据 | | | | 应收账款 | 242,002,127.00 | 219,244,295.00 | | 应收款项融资 | 32,145,843.00 | 29,072,279.00 | | ...

一、召开会议的基本情况 1、股东大会届次：2025年第一次临时股东大会 重庆百亚卫生用品股份有限公司 关于召开2025年第一次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 重庆百亚卫生用品股份有限公司（以下简称"公司"）于2025年8月14日召 开的第四届董事会第七次会议审议通过了《关于召开2025年第一次临时股东大会 的议案》，同意公司于2025年9月5日下午15:00-17:00召开公司2025年第一次临时 股东大会（以下简称"本次股东大会"），现将具体事项公告如下： 证券代码：003006 证券简称：百亚股份 公告编号：2025-037 （2）网络投票时间：2025年9月5日（星期五） 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为深圳证券交 易所交易时间，即：2025年9月5日9:15-9:25，9:30-11:30，13:00-15:00； 通过深圳证券交易所互联网投票系统投票的具体时间为：2025年9月5日 9:15-15:00。 5、会议召开方式 本次会议采取现场表决与网络投票相结合的方式。 现场投票：股东出席现场 ...

重庆百亚卫生用品股份有限公司（以下简称"公司"）第四届监事会第七次 会议于 2025 年 8 月 14 日在公司会议室以现场会议的方式召开。会议通知于 2025 年 8 月 4 日以电话和邮件等电子方式发出。会议应到监事 3 人，实到监事 3 人。 会议由监事会主席陈治芳女士召集并主持，公司董事会秘书及证券事务代表列席 了会议。本次会议的召集及召开程序符合《公司法》和《公司章程》等法律法规、 规章制度的有关规定。 二、监事会会议审议情况 经全体监事充分讨论和认真审议，通过了以下议案： 1、审议通过了《关于<2025 年半年度报告>全文及其摘要的议案》 经审核，监事会认为：董事会编制和审议《2025 年半年度报告》全文及其摘 要的程序符合法律、行政法规和中国证监会、深圳证券交易所的有关规定，报告 内容真实、准确、完整地反映了公司的实际情况，不存在虚假记载、误导性陈述 或者重大遗漏。 证券代码：003006 证券简称：百亚股份 公告编号：2025-034 重庆百亚卫生用品股份有限公司 第四届监事会第七次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 ...

百亚股份（SZ 003006，收盘价：29.68元）8月15日晚间发布半年度业绩报告称，2025年上半年营业收 入约17.64亿元，同比增加15.12%；归属于上市公司股东的净利润约1.88亿元，同比增加4.64%；基本每 股收益0.44元，同比增加4.76%。 （文章来源：每日经济新闻） ...

2025 年 8 月 1 重庆百亚卫生用品股份有限公司 2025 年半年度报告全文 重庆百亚卫生用品股份有限公司 2025 年半年度报告全文 重庆百亚卫生用品股份有限公司 2025 年半年度报告 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实、准确、 完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 公司负责人冯永林、主管会计工作负责人张黎及会计机构负责人(会计主管人员)张黎声 明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 本报告中涉及的公司发展战略和规划等前瞻性陈述，不构成公司对投资者的实质承诺， 投资者及相关人士均应当对此保持足够的风险认识，并且应当理解计划、预测与承诺之间 的差异。 公司面临市场竞争日益加剧、原材料价格大幅度波动和营销网络拓展的风险，具体详细 内容见本报告"第三节管理层讨论与分析"之"十、公司面临的风险和应对措施"，敬请广大投 资者注意。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 | 第一节 | 重要提示、目录和释义 | 2 | | --- ...

Market Overview - The personal care products sector increased by 0.63% on August 15, with Jieya Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3696.77, up 0.83%, while the Shenzhen Component Index closed at 11634.67, up 1.6% [1] Stock Performance - Jieya Co., Ltd. (301108) closed at 26.43, with a rise of 1.69% and a trading volume of 15,100 shares, totaling a transaction value of 39.64 million yuan [1] - Dengkang Oral Care (001328) closed at 43.65, up 1.61%, with a trading volume of 21,600 shares and a transaction value of 93.90 million yuan [1] - Stable Medical (300888) closed at 40.85, increasing by 1.44%, with a trading volume of 65,900 shares and a transaction value of 268 million yuan [1] - Mengni Nursing (605009) closed at 41.47, up 1.15%, with a trading volume of 44,900 shares and a transaction value of 185 million yuan [1] - Zhongshun Jiesang (002511) closed at 8.10, with a slight increase of 0.50%, trading 196,600 shares for a total of 158 million yuan [1] - Reliable Co., Ltd. (301009) closed at 15.00, up 0.47%, with a trading volume of 94,900 shares and a transaction value of 141 million yuan [1] - Baiya Co., Ltd. (003006) closed at 29.68, increasing by 0.44%, with a trading volume of 70,200 shares and a transaction value of 208 million yuan [1] - Liangmian Needle (600249) closed at 5.76, up 0.35%, with a trading volume of 101,700 shares and a transaction value of 5.85 million yuan [1] - Beijia Clean (603059) remained unchanged at 31.64, with a trading volume of 35,200 shares and a transaction value of 111 million yuan [1] - Runben Co., Ltd. (603193) closed at 31.92, down 0.22%, with a trading volume of 52,800 shares and a transaction value of 167 million yuan [1] Fund Flow Analysis - The personal care products sector saw a net inflow of 16.01 million yuan from institutional investors, while retail investors contributed a net inflow of 28.22 million yuan [2] - However, there was a net outflow of 44.24 million yuan from speculative funds [2]

Market Overview - The personal care products sector increased by 1.08% on August 13, with Baiya Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3683.46, up 0.48%, while the Shenzhen Component Index closed at 11551.36, up 1.76% [1] Stock Performance - Baiya Co., Ltd. (stock code: 003006) closed at 29.00, with a rise of 6.42% and a trading volume of 106,100 shares, amounting to a transaction value of 305 million yuan [1] - Other notable stocks include: - Runben Co., Ltd. (603193) closed at 31.50, up 0.57% [1] - Stable Medical (300888) closed at 41.08, up 0.37% [1] - Haoyue Nursing (605009) closed at 40.24, up 0.25% [1] - Reliable Co., Ltd. (301009) remained unchanged at 14.88 [1] - Zhongshun Jierou (002511) closed at 8.17, down 0.37% [1] Capital Flow - The personal care products sector experienced a net outflow of 136 million yuan from institutional investors, while retail investors saw a net inflow of 176 million yuan [2][3] - The capital flow for key stocks includes: - Stable Medical: net outflow of 34.40 million yuan from institutional investors [3] - Reliable Co., Ltd.: net outflow of 20.07 million yuan from institutional investors [3] - Runben Co., Ltd.: net outflow of 6.64 million yuan from institutional investors [3]

Summary of Baia Co., Ltd. Conference Call Company Overview - **Company**: Baia Co., Ltd. - **Industry**: Sanitary products, specifically focusing on women's hygiene products Key Points and Arguments 1. **Recovery in Revenue and Profit**: The most competitive period for online channels has passed, with expectations for revenue and profit to recover, primarily benefiting from L2 strategy optimization and policy restrictions on irrational traffic investments. The months of May and June are seen as clear low points, with July and August showing recovery in GMV on Douyin [2][5] 2. **Dominance of Offline Channels**: Offline channels remain the primary driver for Baia, with the Free Point brand expanding rapidly in peripheral provinces. The first half of the year is expected to see a doubling in growth, and as fixed costs are amortized, profit increases will be non-linear, with key provinces likely to reach profitability inflection points [2][6] 3. **Emergence of Instant Retail**: Baia has positioned itself early in the instant retail space, offering competitive pricing and higher delivery efficiency compared to Douyin. The recovery in e-commerce data combined with strong performance in offline peripheral provinces should be closely monitored for future growth [2][6] 4. **Shift in Growth Strategy**: The company is transitioning from rapid market share growth to enhancing operational quality, leveraging online L2 strategy optimization and new instant retail channels to drive performance growth. The growth cycle of the company is expected to continue [2][7] 5. **Product Strategy and Impact**: In May 2023, Baia launched a probiotic series priced at 1 to 1.2 yuan, which significantly boosted performance and initiated a cycle of large single products. This followed the introduction of a health series in late 2022, which had mixed results due to higher pricing [2][7] 6. **Financial Performance**: Since the second half of 2022, Baia has seen a turning point in performance, with revenue growth of 33% in 2023 and projected 52% in 2024. Despite increased advertising and fixed costs, profit growth remains above 20%. ROE is expected to rise from 15% in 2022 to 20% in 2024, with gross margin increasing from 45% to 53% [4][8] 7. **Regional Market Performance**: Baia holds over 40% market share in the Sichuan-Chongqing region, with stable growth in Yunnan, Guizhou, and Shaanxi. Significant revenue growth is expected in peripheral provinces starting in the second half of 2024, continuing into the first half of 2025 [4][9] 8. **E-commerce and Offline Channel Dynamics**: E-commerce channels have achieved significant results through Douyin and Tmall, but future growth may stabilize at a reasonable range of 20%-30%. The importance of offline channels is increasing, with fixed costs being amortized as scale expands, gradually releasing profit potential [10] 9. **Competitive Advantages**: Baia's local brands, such as Free Point, have stronger offline management capabilities compared to foreign brands, which rely heavily on online channels. The company maintains a close ratio of distributors to sales personnel, enhancing control over terminal sales points and market share [11] 10. **Future Growth Prospects**: As the potential of probiotic products is realized, high-margin products will enhance distributor performance, attracting more distributors. After crossing the breakeven point in various provinces, profit margins are expected to rise rapidly, with projections for continued revenue and profit growth [12]